[Adjuvant chemotherapy in dysgerminoma].
This is a report on a young patient with dysgerminoma of the right ovary. Right-side adnexectomy and hysterectomy were performed initially. Due to the clearly elevated tumour marker levels, indicating an involvement of other germ cell elements, we opted for postoperative chemotherapy instead of radiotherapy. The follow-up included regular monitoring of the tumour markers. To date, there has been no indication towards tumour recurrence.
Fechtig
A
A
Frauenklinik Marienhospital Altenessen, Akademisches Lehrkrankenhaus Universität (GHS) Essen.
de Dycker
R P
RP
Schumacher
T
T
Neumann
R L
RL
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004407:Dysgerminoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D005260:Female; D006801:Humans; D007044:Hysterectomy; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D010052:Ovariectomy; D010053:Ovary / Q000473:pathology
D003520:Cyclophosphamide; D002945:Cisplatin
Adjuvante Chemotherapie beim Dysgerminom.